BackTrxade Health Overview

Trxade Health Cost of Revenue

Cost of Revenue analysis for MEDS.

Quarterly Cost of Revenue

$2.48M
↑ 25721.6% YoY

As of Mar 31, 2026

Annual Cost of Revenue (TTM)

$102.59M
↑ 77668.67% YoY

Trailing 12 months ending Mar 31, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin